
### [NCIT:C3617](http://purl.obolibrary.org/obo/NCIT_C3617)
**Label:** Benign Ureter Neoplasm

**Subclasses:** [NCIT:C6161](http://purl.obolibrary.org/obo/NCIT_C6161) (Ureter Leiomyoma), [NCIT:C6160](http://purl.obolibrary.org/obo/NCIT_C6160) (Ureter Urothelial Papilloma), [NCIT:C4530](http://purl.obolibrary.org/obo/NCIT_C4530) (Ureter Polyp), [NCIT:C6174](http://purl.obolibrary.org/obo/NCIT_C6174) (Ureter Inverted Papilloma), 

**Class expressions from DL-Learner:**

- Thing 52.26%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39088](http://purl.obolibrary.org/obo/NCIT_C39088) (G2/M Checkpoint Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39079](http://purl.obolibrary.org/obo/NCIT_C39079) (Fc Epsilon Receptor I Signaling Pathway BioCarta))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39072](http://purl.obolibrary.org/obo/NCIT_C39072) (Erk1/Erk2 MAPK Signaling Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39071](http://purl.obolibrary.org/obo/NCIT_C39071) (Neuronal Survival Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39069](http://purl.obolibrary.org/obo/NCIT_C39069) (ErbB3 Receptor Recycling Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39067](http://purl.obolibrary.org/obo/NCIT_C39067) (EPO Signaling Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39059](http://purl.obolibrary.org/obo/NCIT_C39059) (Map Kinase Inactivation of SMRT Corepressor Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 41.61%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 41.61%


